Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255

Watchlist Manager
Hebei Changshan Biochemical Pharmaceutical Co Ltd Logo
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
Watchlist
Price: 55.21 CNY -2.49% Market Closed
Market Cap: ¥50.7B

Profitability Summary

Hebei Changshan Biochemical Pharmaceutical Co Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Hebei Changshan Biochemical Pharmaceutical Co Ltd

Margins Comparison
Hebei Changshan Biochemical Pharmaceutical Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
52B CNY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
530.8B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
278.2B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
212.8B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
222.3B CHF
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
267.6B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
147.1B USD
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
97.2B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Hebei Changshan Biochemical Pharmaceutical Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
52B CNY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
530.8B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
278.2B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
212.8B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
222.3B CHF
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
267.6B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
147.1B USD
Loading...
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
97.2B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Hebei Changshan Biochemical Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate